Lab Automation Markets, 3rd. Edition (Systems, Key Companies, Forecasts and Trends)

February 2013 | 200 pages | ID: LB9A0491F97EN
Kalorama Information

Abstracts

This report, Lab Automation Markets, 3rd Edition, (Systems, Key Companies, Forecasts and Trends), represents Kalorama Information's latest study of the market for systems that enable labs to store, identify and transport large quantities of specimens. The report analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for clinical diagnostics and drug discovery research laboratories.

Many clinical laboratories are facing a number of issues that are challenging their ability to remain competitive. These challenges have been caused by the reduction of government reimbursement rates for laboratory tests, cost-restraint measures established by the managed care industry, and the continuing trend toward containment of national health care costs. In order to survive in the future, it will be necessary for labs to run more tests; test in fewer sites; operate with less equipment; maintain lower operating costs; hire less skilled labor; and harness additional automation.

Since the last edition, systems have been introduced, market share has shifted and alliances and mergers have concluded. These are some of the recent developments that are assessed in the report and considered in market projections:

• Fully Automated Systems
• Mergers and Acquisitions Alter the Commercial Landscape
• Co-Development, Co-Marketing, Co-Selling
• Automation Solves Sample Lysis Bottleneck
• Automation for Secondary Screening
• Pfizer UCB Partnership
• BioTrove Acquisition
• PerkinElmer Caliper Acquisition
• BD Kiestra Acquisition
• Labotix and NoemaLife Collaboration
• Higher-Throughput Drug Discovery Automation
• Blood Sciences Laboratory Automation
• Optimizing Liquid Handling
• Bench top Platform Controls Automation
• Integrated Laboratory Automation

In its previous two editions, the report has been a useful tool for business planning for top automation companies. The report allows companies to benefit from estimates of the part of the market most beneficial to them. Current Market and Forecasts to 2017 for the following segments are included:

• Sample Transport Systems
• Specimen Handling Systems
• Storage and Retrieval Systems
• Work Stations
• Plate Readers
• Robotics
• Dissolution Testing
• Laboratory Information Management Systems (LIMS)

As a report with international focus, markets for North America, Europe and Asia are provided. Revenues for clinical labs and drug discovery labs are broken out.Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies.

Contents

1 EXECUTIVE SUMMARY

1.1 Indispensable Technology
  1.1.1 Competitive Pressures for the Clinical Lab
    Key Processes to Automate
  1.1.2 Automation Speeds Drug Discovery
    Variety of Processes
1.2 Trending Toward Customization, Speed and Standardization
  1.2.1 Miniaturization
1.3 Advantages and Trade-Offs
1.4 Market Overview

2 INTRODUCTION

2.1 Overview
  2.1.1 Benefits of Automation
2.3 The Drug Discovery Laboratory
2.2 The Clinical Laboratory
  2.2.1 The Labor Challenge
2.3 The Drug Discovery Laboratory
  2.3.1 Increasing Throughput
2.4 New Range of Tools
2.5 Planning and Management
2.6 Key Issues
  2.6.1 Issues in the Clinical Laboratory
  2.6.2 Issues in the Drug Discovery Laboratory
  2.6.3 Work Flow
  2.6.4 Labor Issues
  2.6.5 Operating Costs
  2.6.6 Compatibility
2.7 Targets for Automation
  2.7.1 Liquid Handling
  2.7.2 Test Tube Processing
  2.7.3 Decapping
  2.7.4 Microplates and Microarrays
2.8 Health Care Trends Impacting Automation
  2.8.1 Affordable Care Act Tax Impact
2.9 Automation Equipment Trends
  2.9.1 Miniaturization
  2.9.2 Standards, Connectivity and Integration
2.10 Total Lab Automation
2.11 Modular Automation
2.12 FDA Regulation
2.13 Reimbursement
  2.13.2 Assessing Outcomes

3 ISSUES AND TRENDS

3.1 Danaher Acquires Beckman Coulter
3.2 Roche Acquisition
3.3 Pfizer, UCB Partnership Speeds Drug Discovery
3.4 Labotix Acquisition
3.5 Life Technologies Acquires BioTrove
3.6 PerkinElmer Acquires Caliper
3.7 BD Acquires Kiestra
3.8 Labotix, NoemaLife Collaborate to Optimize Efficiency
3.9 Fully Automated System
3.10 Expanding to Laboratory Automation
3.11 Partnering
3.12 Co-Development, Co-Marketing, Co-Selling
3.13 Automation Solves Sample Lysis Bottleneck
3.14 Automation for Secondary Screening
3.15 Higher-Throughput Drug Discovery Automation
3.16 Blood Sciences Laboratory Automation
3.17 Optimizing Liquid Handling
3.18 Bench top Platform Controls Automation
3.19 Integrated Laboratory Automation
3.20 Automated Stem-Cell Picker

4 MARKETS

4.1 A World Market Perspective
  4.1.1 Merges and Acquisitions Alter the Commercial Landscape
4.2 Clinical Lab Automation Markets
  4.2.1 Sample Transport Systems
  4.2.2 Storage-Retrieval Systems
  4.2.3 Work Stations
  4.2.4 Specimen Handling Systems
  4.2.4 LIMS
4.3 Drug Discovery Lab Automation Markets
  4.3.1 Plate Readers
  4.3.2 Automated Liquid Handling Systems
  4.3.3 Robotics
  4.3.4 Dissolution Testing
  4.3.5 LIMS
  4.3.6 Storage-Retrieval.Systems
4.4 Market Share in Lab Automation

5 COMPANY PROFILES

5.1 Abbott Diagnostics
5.2 Agilent Technologies Inc.
5.3 Ai Scientific
5.4 Aurora Biotechnologies (Nexus)
5.5 Beckman Coulter Inc.
5.6 BD (Becton, Dickinson and Company)
5.7 BioTrove
5.8 Brooks Automation Inc.
5.9 Caliper Life Sciences
5.10 Dynacon Inc.
5.11 Eppendorf AG
5.12 Hamilton Storage Technologies Inc.
5.13 InnovaSystems Inc.
5.14 Labotix Automation Inc.
5.15 LabVantage Solutions Inc.
5.16 Molecular Devices
5.17 Motoman Robotics Division
5.18 Olympus Corp.
5.19 Peak Analysis and Automation
5.20 PerkinElmer Life and Analytical Sciences Inc.
5.21 F. Hoffmann-La Roche Ltd.
5.22 RTS Life Science
5.23 Siemens Healthcare
5.24 Sotax
5.25 SSi Robotics
5.26 TAP Biosystems
5.27 Tecan Group Ltd.
5.28 ThermoFischer Scientific Inc.
5.29 Wako Automation
5.30 Xiril AG

About

The reduction of government reimbursement rates for laboratory tests and managed care cost-restraint measures have increased pressures for clinical labs to become more productive and cost efficient. The quest for efficiency, however, is confronted with the decreasing availability of trained laboratory technologists and an expanding menu of diagnostic testing protocols. This is where lab automation steps in, according to Kalorama Information's report on the topic, and it's a key driver of this $10.4 billion market.

The above mentioned issues are challenging the ability of many clinical laboratories to remain competitive. In order to survive in the future, it will be necessary for labs to run more tests; test in fewer sites; operate with less equipment; maintain lower operating costs; hire less skilled labor; and harness additional automation. 

This report represents Kalorama Information's latest study of the market for systems that enable labs to store, identify and transport large quantities of specimens. The report analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for clinical diagnostics and drug discovery research laboratories. 

Since the last edition, new systems have been introduced, market share has shifted and alliances and mergers have concluded. The following are some of the recent developments that are assessed in the report and considered in market projections:

• Mergers and Acquisitions Alter the Commercial Landscape
• Co-Development, Co-Marketing, Co-Selling
• Automation Solves Sample Lysis Bottleneck
• Automation for Secondary Screening
• Pfizer UCB Partnership
• BioTrove Acquisition
• PerkinElmer Caliper Acquisition
• BD Kiestra Acquisition
• Labotix and NoemaLife Collaboration
• Higher-Throughput Drug Discovery Automation
• Blood Sciences Laboratory Automation
• Optimizing Liquid Handling
• Bench top Platform Controls Automation
• Integrated Laboratory Automation

Lab Automation Markets, 3rd. Edition (Systems, Key Companies, Forecasts and Trends) is an essential business planning tool for top automation companies. It allows companies to benefit from estimates of that part of the market which is most beneficial to them. Detailed company profiles of 30 key industry players help in assessing the competition.